Skip to main content
Clinical Trials/ISRCTN72571312
ISRCTN72571312Completed未知

A double-blind, placebo-controlled, crossover-designed GABA tea pilot study in children diagnosed with Autism Spectrum Conditions

Coventry University0 sites9 target enrollmentStarted: November 21, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
9

Study Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31060476 (added 08/05/2019)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Diagnosis of ASC
  • 2. No known co-occurring ADHD, genetic or medical conditions
  • 3. No current medication
  • 4. A willingness to drink tea
  • 5. The ability to wear a watch without tactile sensitivity
  • 6. Younger than 14 (due to a large increase in testosterone levels after this point (Mayo Foundation for Medical Education and Research website, 1995-2017))
  • 7. Both parent and child commitment to four university visits and precise tea making and drinking requirements

Exclusion Criteria

  • 1. No diagnosis of ASC
  • 2. Known co-occurring ADHD
  • 3. Genetic or medical conditions
  • 4. Current medication
  • 5. An unwillingness to drink tea
  • 6. Difficulty in wearing a watch due to tactile sensitivity
  • 7. Older than 14 (due to a large increase in testosterone levels after this point (Mayo Foundation for Medical Education and Research website, 1995-2017))
  • 8. Both parent and child uncommited to four university visits and precise tea making and drinking requirements

Investigators

Similar Trials